BackBlueprint Medicines Overview
Blueprint Medicines Corp

Blueprint Medicines Target Price

Analysts' 12-month price predictions for BPMC.

Share Price

$128.35

Average Target Price

$141.009.9% upside

2 analysts in the last 4 months

High: $150 | Low: $132

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2025-06-03GuggenheimMichael Schmidt$1322.8% upsideOpen
2025-03-07Scotiabank$15016.9% upsideOpen
2024-10-31NeedhamAmi Fadia$1355.2% upsideOpen
2024-10-24UBSDavid Dai$8831.4% downsideOpen
2024-09-19Stifel NicolausBradley Canino$15520.8% upsideOpen
2024-08-01OppenheimerMatthew Biegler$1301.3% upsideOpen
2024-07-29BarclaysPeter Lawson$10518.2% downsideOpen
2024-07-08OppenheimerMatthew Biegler$1252.6% downsideOpen
2024-05-06Leerink PartnersAndrew Berens$9724.4% downsideOpen
2024-05-03Raymond JamesChristopher Raymond$10419% downsideOpen
2024-05-03H.C. WainwrightAndrew Fein$1355.2% upsideOpen
2022-12-14Needham$6053.3% downsideOpen
2022-11-02H.C. WainwrightAndrew Fein$7045.5% downsideOpen
2022-09-06OppenheimerMatthew Biegler$9029.9% downsideOpen
2022-08-17Wells FargoDerek Archila$4168.1% downsideOpen
2022-05-18Piper SandlerChristopher Raymond$6549.4% downsideOpen
2022-02-01Morgan StanleyMichael Ulz$9228.3% downsideOpen
2022-01-03GuggenheimMichael Schmidt$1224.9% downsideOpen
2021-11-09Raymond JamesDane Leone$1333.6% upsideOpen
2021-07-29Goldman SachsSalveen Richter$14714.5% upsideOpen
2021-06-17Canaccord GenuityArlinda Lee$1206.5% downsideOpen